Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Biotech Stocks That Could Skyrocket This Year

TheMotleyFool

0 0

2 Biotech Stocks That Could Skyrocket This Year

Investing in small-cap, clinical-stage biotech stocks can be a double-edged sword. While shares of these companies can skyrocket following positive clinical or regulatory news, they can just as quickly lose a substantial amount of their value in a short period if things don't go their way.

In other words, jumping into these waters is a risky proposition, but you have above-average risk tolerance, it can turn out to be a lucrative move. With that in mind, let's turn to two biotech stocks that could soar (and provide above-average returns to patient investors): Krystal Biotech (NASDAQ: KRYS) and Editas Medicine (NASDAQ: EDIT).